[Status epilepticus in chronically dialyzed patients treated with erythropoietin].Riv Neurol. 1991 Nov-Dec; 61(6):215-8.RN
Abstract
This paper describes the clinical features of two patients with chronic renal failure and uremic anaemia treated with recombinant human erythropoietin (9000 I.U. subcutaneously subdivided in 3 times weekly at the end of haemodialysis treatment) who developed seizures and status epilepticus. This treatment has unequivocal benefits but in some patients has been accompanied by elevated blood pressure leading to hypertensive encephalopathy with seizures. In fact, the correction of the anaemia results in a rise in packed cell volume with a consequent increase in blood viscosity, predisposing to increased vascular resistance and the development of hypertension.
MeSH
Pub Type(s)
Case Reports
English Abstract
Journal Article
Language
ita
PubMed ID
1813973
Citation
Massetani, R, et al. "[Status Epilepticus in Chronically Dialyzed Patients Treated With Erythropoietin]." Rivista Di Neurologia, vol. 61, no. 6, 1991, pp. 215-8.
Massetani R, Galli R, Calabrese R, et al. [Status epilepticus in chronically dialyzed patients treated with erythropoietin]. Riv Neurol. 1991;61(6):215-8.
Massetani, R., Galli, R., Calabrese, R., Sartucci, F., Rindi, P., Severino Brandi, L., & Murri, L. (1991). [Status epilepticus in chronically dialyzed patients treated with erythropoietin]. Rivista Di Neurologia, 61(6), 215-8.
Massetani R, et al. [Status Epilepticus in Chronically Dialyzed Patients Treated With Erythropoietin]. Riv Neurol. 1991 Nov-Dec;61(6):215-8. PubMed PMID: 1813973.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
AU - Massetani,R,
AU - Galli,R,
AU - Calabrese,R,
AU - Sartucci,F,
AU - Rindi,P,
AU - Severino Brandi,L,
AU - Murri,L,
PY - 1991/11/1/pubmed
PY - 1991/11/1/medline
PY - 1991/11/1/entrez
SP - 215
EP - 8
JF - Rivista di neurologia
JO - Riv Neurol
VL - 61
IS - 6
N2 - This paper describes the clinical features of two patients with chronic renal failure and uremic anaemia treated with recombinant human erythropoietin (9000 I.U. subcutaneously subdivided in 3 times weekly at the end of haemodialysis treatment) who developed seizures and status epilepticus. This treatment has unequivocal benefits but in some patients has been accompanied by elevated blood pressure leading to hypertensive encephalopathy with seizures. In fact, the correction of the anaemia results in a rise in packed cell volume with a consequent increase in blood viscosity, predisposing to increased vascular resistance and the development of hypertension.
SN - 0035-6344
UR - https://www.unboundmedicine.com/medline/citation/1813973/[Status_epilepticus_in_chronically_dialyzed_patients_treated_with_erythropoietin]_
DB - PRIME
DP - Unbound Medicine
ER -